The oral solid dose (OSD) market is $335 billon with a low growth rate of <1 percent over the last 5 years. It is causing a shift in how companies plan and execute the development and manufacturing of OSD drug products. Thermo Fisher Scientific provides a range of early development OSD solutions that can address your small molecule’s unique needs and challenges, while being backed my technical experts and a global network. Leverage our early development services to help:
Learn about our Oral Solid Dose Dosage Forms.